Health Leads UK Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 03403833

Health Leads UK Limited

Filleted Unaudited Financial Statements

31 July 2025

Health Leads UK Limited

Financial Statements

Year ended 31 July 2025

CONTENTS	PAGE

Officers and professional advisers	1

Statement of financial position	2

Notes to the financial statements	4

Health Leads UK Limited

Officers and Professional Advisers

The board of directors	Mr H L Morgan (Appointed 16th September 2025)
	Mr J C Doyle (Resigned 16th September 2025)

Company secretary	Mr D V Harvey (Resigned 4 August 2025)

Registered office	Unit 1 Horeb Business Park
	Horeb
	Llandysul
	Ceredigion
	Wales
	SA44 4JG

Accountants	James & Uzzell Ltd
	Chartered Certified Accountants
	Axis 15, Axis Court
	Mallard Way
	Riverside Business Park
	Swansea
	SA7 0AJ

Health Leads UK Limited

Statement of Financial Position

31 July 2025

	2025	2024
Note	£	£

FIXED ASSETS

Intangible assets	5	22,554	35,024
Tangible assets	6	271,251	264,464
		---------	---------
		293,805	299,488

CURRENT ASSETS

Stocks	7	167,271	257,635
Debtors	8	87,187	99,563
Cash at bank and in hand		156,948	25,336
		---------	---------
		411,406	382,534

CREDITORS: amounts falling due within one year	9	175,636	223,959
		---------	---------
NET CURRENT ASSETS		235,770	158,575
		---------	---------
TOTAL ASSETS LESS CURRENT LIABILITIES		529,575	458,063

PROVISIONS	52,080	–
	---------	---------
NET ASSETS	477,495	458,063
	---------	---------

CAPITAL AND RESERVES

Called up share capital	10	800	800
Capital redemption reserve		200	200
Profit and loss account		476,495	457,063
		---------	---------
SHAREHOLDERS FUNDS		477,495	458,063
		---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Health Leads UK Limited

Statement of Financial Position (continued)

31 July 2025

These financial statements were approved by the board of directors and authorised for issue on 28 April 2026 , and are signed on behalf of the board by:

Mr H L Morgan

Director

Company registration number: 03403833

Health Leads UK Limited

Notes to the Financial Statements

Year ended 31 July 2025

1. GENERAL INFORMATION

Health Leads UK Limited is a company limited by shares incorporated in Wales within the United Kingdom. The address of the registered office is given in the company information on page 3 of these financial statements. The nature of the company's operations and principal activities are manufacturing other food products not elsewhere classified.

2. STATEMENT OF COMPLIANCE

The financial statements have been prepared in accordance with applicable accounting standards including Financial Reporting Standard 102 'The Financial Reporting Standard Applicable in the UK and Republic of Ireland (FRS 102)', Section 1A for Small Entities and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparation

The financial statements have been prepared on a going concern basis under the historical cost convention, modified to include certain items at fair value. The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1. The reporting period of these financial statements and its comparative period is 12 months. These financial statements only include the results of the individual entity made up to 31 July 2025. The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Employee benefits

When employees have rendered service to the company, short-term employee benefits to which the employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service. The company operates a defined contribution plan for the benefit of its employees. Contributions are expensed as they become payable.

Going concern

The director has considered the future trading position of the company and is confident that the going concern principle can be applied to the financial statements.

Loans and borrowings

Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.

Provisions

Provisions are recognised when the company has an obligation at the balance sheet date as a result of a past event, it is probable that an outflow of economic benefits will be required in settlement and the amount can be reliably estimated.

Critical accounting estimates and assumptions

The company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are addressed below

(i) Useful economic lives of tangible assets

The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets. See note for the carrying amount of the property plant and equipment, and the depreciation accounting policy for the useful economic lives for each class of assets.

(ii) Impairment of debtors

The company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management considers factors including the current credit rating of the debtor, the ageing profile of debtors and historical experience. See note for the net carrying amount of the debtors and associated impairment provision.

(iii) Goodwill and intangible fixed assets

Accounting standards require the recognition of intangible assets as part of a business combination. The methods used to value such intangible assets require the use of estimates. Future results are impacted by the amortisation periods adopted and changes to the estimated useful lives would result in different effects on the profit and loss account and balance sheet. Goodwill is amortised and tested at least annually for impairment along with finite lives of intangible assets and other assets. Tests for impairment are based on subjective assumptions.

(iv) Stock provisioning

The company sells vitamins and minerals and is subject to consumer demands. As a result it is necessary to consider the recoverability of the cost of stock and the associated provisioning required. When calculating the stock provision, management considers the nature and condition of the stock, as well as applying assumptions around anticipated saleability

(v) Going Concern

The assessment of going concern may include the use of critical judgements in respect of impact of various external factors such as political, economic and social issues. Material uncertainties are considered in this regard

(vi) Provisions

Estimates are used in determining the value of provisions when recognised. This will be based on historical information, known expectations and reasonable outcomes

Debtors and creditors receivable/payable within one year

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably. Interest income is recognised using the effective interest method.

Tax

Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that apply to the sale of the asset.

Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.

Intangible assets

Intangible assets acquired separately from a business are capitalised at cost. Intangible assets acquired on business combinations are capitalised separately from goodwill if the fair value can be measured reliably on initial recognition. Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Software	-	20% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Property Improvements	-	10% straight line
Plant and machinery	-	15% reducing balance
Fixtures and fittings	-	25% straight line

Impairment

Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset’s cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing stock to its present location and condition. Cost is calculated using the first-in, first-out formula. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

4. EMPLOYEE NUMBERS

The average number of persons employed by the company during the year amounted to 18 (2024: 18 ).

5. INTANGIBLE ASSETS

	Software
	£
Cost
At 1 August 2024	70,514
Additions	1,920
	--------
At 31 July 2025	72,434
	--------
Amortisation
At 1 August 2024	35,490
Charge for the year	14,390
	--------
At 31 July 2025	49,880
	--------
Carrying amount
At 31 July 2025	22,554
	--------
At 31 July 2024	35,024
	--------

6. TANGIBLE ASSETS

	Property Improvements	Plant and machinery	Fixtures and fittings	Total
	£	£	£	£
Cost
At 1 August 2024	108,880	675,361	39,295	823,536
Additions	–	52,718	2,047	54,765
	---------	---------	--------	---------
At 31 July 2025	108,880	728,079	41,342	878,301
	---------	---------	--------	---------
Depreciation
At 1 August 2024	103,869	418,446	36,757	559,072
Charge for the year	2,129	44,114	1,735	47,978
	---------	---------	--------	---------
At 31 July 2025	105,998	462,560	38,492	607,050
	---------	---------	--------	---------
Carrying amount
At 31 July 2025	2,882	265,519	2,850	271,251
	---------	---------	--------	---------
At 31 July 2024	5,011	256,915	2,538	264,464
	---------	---------	--------	---------

7. STOCKS

	2025	2024
	£	£
Raw materials and consumables	167,271	257,635
	---------	---------

8. DEBTORS

	2025	2024
	£	£
Trade debtors	46,998	46,478
Other debtors	40,189	53,085
	--------	--------
	87,187	99,563
	--------	--------

9. CREDITORS: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	42,359	86,378
Social security and other taxes	51,995	67,882
Other creditors	81,282	69,699
	---------	---------
	175,636	223,959
	---------	---------

10. CALLED UP SHARE CAPITAL

Issued, called up and fully paid

	2025		2024
	No.	£	No.	£
Ordinary shares of £ 1 each	800	800	800	800
	----	----	----	----